RECRUITING

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.

Official Title

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

Quick Facts

Study Start:2024-10-10
Study Completion:2028-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06598397

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Status as HIV+
  2. * Age 18 or older
  3. * Currently smokes ≥ 5 CPD, on average, in past month, carbon monoxide ≥ 7 ppm and positive salivary cotinine
  4. * Able to understand the nature of the study and the consenting process
  5. * Is engaged in HIV clinical care
  6. * Living in larger NYC metropolitan area currently and for the next 6-8 months
  1. * Suffer from any medical condition or contraindication precluding use of nicotine replacement therapy
  2. * Current use of any tobacco cessation medications (varenicline, NRT patch, gum, lozenge, spray or inhaler, or bupropion, including the use of bupropion/Wellbutrin for depression)
  3. * Currently participating in a smoking cessation program
  4. * Pregnant or nursing and plans to be in next 6 months
  5. * Has a serious or untreated psychiatric illness (bipolar or schizophrenia/schizo-affective disorder)
  6. * Has a past 6-month psychiatric hospitalization or psychiatric emergency room visit does not have a functioning mobile phone that can receive text messages

Contacts and Locations

Study Contact

Jennifer Cantrell, DrPH, MPA
CONTACT
212-998-5797
jennifer.cantrell@nyu.edu

Study Locations (Sites)

New York University School of Global Public Health
New York, New York, 10003
United States

Collaborators and Investigators

Sponsor: New York University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-10
Study Completion Date2028-06

Study Record Updates

Study Start Date2024-10-10
Study Completion Date2028-06

Terms related to this study

Keywords Provided by Researchers

  • MOST
  • multiphase optimization strategy
  • implementation
  • HIV clinical care

Additional Relevant MeSH Terms

  • Human Immunodeficiency Virus (HIV)
  • Smoking Cessation